Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03665454 · ClinicalTrials.gov registry record · Phase 1
PF 06412562 in Subjects With Advanced Stage Parkinson's Disease
A Phase 1 study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
NCT03665454 is a Phase 1 study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 8 participants.
The verdict
NCT03665454, a Phase 1 study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to test the safety and tolerability of the investigational drug PF-06412562 compared to the current medical standard of care medication for Parkinson's disease, carbidopa/levodopa. This research also is being done to find out if the investigational drug PF-06412562 can help improve the motor (movement) function, alertness, and cognitive (thinking) skills of people who are considered to be in the advanced-stage of Parkinson's disease. In this study, PF06412562 is 'investigational,' which means that it is experimental and has not been approved by the US Food and Drug Administration (FDA), but can be used in clinical research studies such as this one.
Interventions
- DRUG PF-06412562
- DRUG Standard of Care Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2018-09-24 |
| Est. Completion | 2019-04-21 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03665454
The ClinicalTrials.gov registry entry for NCT03665454 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PF-06412562 is the first listed.
NCT03665454 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03665454 about?
NCT03665454 is a clinical study titled "PF 06412562 in Subjects With Advanced Stage Parkinson's Disease". The purpose of this study is to test the safety and tolerability of the investigational drug PF-06412562 compared to the current medical standard of care medication for Parkinson's disease, carbidopa/levodopa. This research also is being done to find out if the investigational drug PF-06412562 can h...
What is the current status of trial NCT03665454?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2018-09-24. Estimated completion is 2019-04-21.
What interventions are being tested in trial NCT03665454?
The interventions under investigation include: PF-06412562 (DRUG), Standard of Care Placebo (DRUG).
Who is sponsoring clinical trial NCT03665454?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.